This is a procedural filing with no new financial data, the exchange offer is the next step in the previously announced MiniMed separation. MDT holders should evaluate whether to tender based on their view of MMED's standalone prospects vs. MDT's simplified portfolio. The final exchange ratio (announced Oct 7) and proration risk will determine the economic outcome. No immediate trading catalyst for MDT.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 14 $93.80entry
- T+1 · 2mo ago −0.05%α +0.41% · $93.75
- T+5 · 8w ago −2.19%α −2.29% · $91.75
- T+20 · 5w ago −1.99%α −4.26% · $91.93
- T+45 · todayOpen
- T+60 · in 21d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Medtronic has formally launched an exchange offer to split off its remaining ~89.86% stake in MiniMed (MMED), offering up to 225,361,295 MiniMed shares in exchange for MDT shares at a ~7.5% premium ($107.53 of MMED per $100 of MDT). The offer expires October 9, 2026, and is expected to be tax-free under Section 355. This is a routine procedural milestone in the separation process announced in May 2025, no new financial data, no opposition, and no changes to deal terms. The filing is informational only and does not alter Medtronic's standalone outlook.
Key Facts
- Medtronic is offering up to 225,361,295 newly issued MiniMed shares (80.1% of MMED) in exchange for MDT shares at a ~7.5% premium ($107.53 of MMED per $100 of MDT).
- If oversubscribed, Medtronic may accept an additional 27,452,053 MMED shares (the De Minimis Increase Amount), divesting its full 89.9% stake.
- The exchange ratio is based on 3-day VWAP averaging (Oct 5-7, 2026), with an upper limit of 4.5939 MMED shares per MDT share (a 12% discount floor).
- The offer expires October 9, 2026; shareholders can withdraw tendered shares anytime before expiration.
- The transaction is expected to be tax-free under Section 355 of the Internal Revenue Code.
- Medtronic will redeem and cancel all MDT shares acquired in the exchange, reducing share count without using cash.
- MiniMed does not expect to pay dividends for the foreseeable future.
- Conditions include minimum tender of 112,680,647 MMED shares and receipt of a tax opinion from Skadden.
Financial Impact
Medtronic will reduce its outstanding share count by up to ~49 million shares (at a 4.5939 exchange ratio) without cash outlay. The net book value difference vs. market value will be recognized as a gain or loss on disposal.
Risk Factors
- Exchange offer may be undersubscribed, leaving Medtronic with a residual ~9.76% stake requiring a separate clean-up divestment.
- Upper limit on exchange ratio could reduce the effective premium if MMED underperforms MDT during the averaging period.
- Market disruption events could delay or terminate the offer.
- The registration statement (S-4) has not yet been declared effective by the SEC, delaying completion.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 16 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (MDT), Batch item 1 | 0001628280-26-061694 |
| Document: 0001628280-26-061694-index-headers.html | 0001628280-26-061693 |
| Document: 0001628280-26-061694-index.html | 0001628280-26-061692 |
| Document: 0001628280-26-061694.txt | 0001628280-26-061691 |
| 425 Filing (MDT), Batch item 5 | 0001628280-26-061693 |
| Document: 0001628280-26-061693-index-headers.html | 0001628280-26-061694 |
| Document: 0001628280-26-061693-index.html | 0001628280-26-061694 |
| Document: 0001628280-26-061693.txt | 0001628280-26-061694 |
| 425 Filing (MDT), Batch item 9 | 0001628280-26-061692 |
| Document: 0001628280-26-061692-index-headers.html | 0001628280-26-061694 |
| Document: 0001628280-26-061692-index.html | 0001628280-26-061694 |
| Document: 0001628280-26-061692.txt | 0001628280-26-061694 |
| 425 Filing (MDT), Batch item 13 | 0001628280-26-061691 |
| Document: 0001628280-26-061691-index-headers.html | 0001628280-26-061694 |
| Document: 0001628280-26-061691-index.html | 0001628280-26-061694 |
| Document: 0001628280-26-061691.txt | 0001628280-26-061694 |
Track record
53 reports on MDT
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +15.30% at T+60 after the Jun 3, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 16, 2026today Press Release Neutral 4/10 Entry price pending
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $101.59 Now $102.88 +1.27% settles Feb 8
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $98.88 Now $102.88 +4.05% settles Feb 1
- Oct 19, 202628d ago 8-K Neutral 4/10 Entry $94.63 Now $102.88 +8.72% settles Jan 15
- Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
- Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
- Oct 15, 20264w ago 144 Neutral 3/10 Entry $95.45 Now $102.88 +7.78% settles Jan 12
- Oct 14, 20264w ago SC TO-I/A Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
- Oct 14, 20264w ago 425 Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
- Oct 13, 20264w ago SC TO-I/A Neutral 5/10 Entry $93.01 Now $102.88 +10.61% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers